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Purpose: Whether HIV infection itself and/or antiretroviral agents (ARV)
have impact on carotid atherosclerosis, assessed using the carotid intima
media thickness (IMT), is still debated.
Methods: 100 HIV-infected patients (HIV+) (50 ARV-treated >4 years,
50 ARV-naïve but HIV-infected >2 years) and 50 HIV-negative controls were
recruited in age-matched never-smoking male triads. Carotid IMT was measured
in a total of 12 segments. Pro- (hs-CRP, Resistin, IL-6, IL-18, Insulin, Serum
Amyloid A, D-Dimer) and anti-inflammatory (total and high molecular weight
adiponectin, IL-27, IL-10) markers were dichotomized into high/low scores (based
on median values). Carotid IMT was compared across HIV/treatment groups,
stratified by HIV-infection duration, or inflammatory profiles using linear regres-
sion models adjusted for age, diabetes, prior hypertension.
Results: The mean age was 41.2 years (SD=6.7). In HIV+ patients, and
median duration of HIV-infection was 7.9 years (IQR=7.6). After excluding 1 elite
controller subject (<50 copies/mL, ARV-naïve), and adjusting for nadir CD4+
count, average carotid IMT was thicker with longer (>7.9years) HIV-infection,
irrespective of ARV treatment (ARV-treated 760μm±10, ARV-naïve 757±17 μm)
when compared to shorter (<7.9years) HIV-duration (ARV-treated 731±16 μm,
ARV-naïve 731±10μm). ARV-treated subjects with >7.9 years of HIV-infection
had significantly thicker carotid IMT than ARV-naïve subjects with <7.9 years of
HIV-infection (P<.05). Having a low anti-inflammatory profile was associated
with thicker carotid IMT, irrespective of high- or low-proinflammatory markers
(760±9 μm and 768±13 μm, respectively) when compared to subjects with high
anti-inflammatory profiles (712±11 μm and 737±12 μm, for high and low pro-
inflammatory profile respectively) (p<.05).
Conclusion: HIV duration, but not ARV treatment, is associated with
thicker carotid IMT. Low levels of anti-inflammatory markers highly correlate
with thicker carotid IMT.
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Introduction: Familial amyloid polyneuropathy (FAP) is an autosomic
disease caused by the mis-folding of mutated transthyretin. Cardiopathy due
to FAP associates cardiac infiltration and dennervation. The aim of the study
was to characterize the relationship between blood pressure profile and cardiac
amyloidosis.
Methods and results: In a cohort of consecutive 32 FAP patients, we per-
formed ABPM and a standard evaluation including echocardiography, right
ventricular catheterism and heart rate variability.
Non-dipping pattern was documented in 81.3%(26/32) in FAP. Non dipper
patients displayed higher cardiac infiltration assessed by echo (cf. table). Dip-
ping of systolic blood pressure were negatively correlated to relative wall
thickness (RWT) (Rho=–0.038; P=0.047).
Conclusion: A non dipping pattern was common in cardiac amyloidosis
due to FAP. This pattern was correlated to the severity of cardiac infiltration
measured by echocardiography. ABPM may be a promising tool to evaluate
the severity of the myocardial infiltration in cardiac amyloidosis.
Table – Main results (RWT: relative wall thickness)
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Background: The prevalence of masked arterial hypertension seems to be
high in patients with Obstructive Sleep Apnea Syndrome (OSAS). MH has
been associated with a higher risk of cardiovascular events. The aim of this
study was to evaluate the prevalence of MH and the different types of arterial
hypertension (AH) in a large population of patients with OSAS.
Methods. Clinical blood pressure and twenty-four-hour ambulatory blood
pressure monitoring were systematically performed in 253 consecutive
patients with documented OSAS. MH was defined as a normal blood pressure
(BP) in the clinic or office (<140/90 mmHg), but an elevated BP out of the
clinic (ambulatory daytime BP or home BP>135/85 mmHg).
Results. Two hundred and fitfy-three subjects (mean age 51.3±9.5 years,
83% of men, mean BMI 31.8±5.8 kg/m², mean Apnea-Hypopnea Index (AHI)
52.9±28.5%) with OSAS were included. Eighty-two patients (32%) had
known AH. Among the 171 (68%) without known AH, 55 (32%) were
normotensive, 25 (15%) had white coat AH, 52 (30%) had newly diagnosed
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Variable FAP total FAP dipper FAP non dipper P
n 32 19% (6) 81% (26)
age 55,4±11,3 52,1±11,3 56,1±13,3 0.38
% of male 69% (22/32) 83% (05/06) 65% (17/26) 0.71
BMI (kg/m2) 24,6±3,9 24,0±5,8 24,8±3,6 0.90
echocardiography
IVS (mm) 12,5±4,4 10,0±2,36 13,1±4,6 0.1
PW (mm) 11,0±3,0 9,0±1,2 11,4±3,2 0.09
LVDD(mm) 44.6±3.8 45,8±2,9 44,4±4.0 0.44
LVEF (%) 60,2±9.0 65,0±5,5 59.0±9,4 0.038
RWT 0,499±0,153 0,394±0,055 0,522±0,158 0.048
Catheterism
PCWP (mmHg) 8,8±4,6 6,8±3,1 9,2±4,8 0.21
CI (L/min/m2) 2,7±0,5 2,9±0,5 2,7±0,5 0.35
HRV
mean heart rate 75,2±13.9 76,8±14,1 74.9±14,2 0.95
sdnn 89.9±40.7 92,1±26,5 86,3±44,2 0.48
